Intelligence · Clinical Development
Pipeline search results
Programs matching “placebo” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 588 pipeline programs matching "placebo" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
Lutikizumab, Placebo of Lutikizumab
AbbVie Deutschland GmbH & Co. KG
Hidradenitis Suppurativa
1 trial -
MEDI4736 Placebo, DURVALUMAB
CERO THERAPEUTICS HOLDINGS, INC.
Completely resected primary stage IB (≥ 4cm), II and IIIA non-small cell lung cancer patients
1 trial -
MITAPIVAT, Placebo for Mitapivat
Lacuna Pharma Pty Ltd
Transfusion-Dependent Alpha- or Beta-Thalassemia
1 trial -
MK-0616, Placebo to MK-0616
Merck Sharp and Dohme
Heterozygous Familial Hypercholesterolemia in pediatric patients
1 trial -
MK-0616, Placebo to MK-0616 - Tablet
Merck Sharp and Dohme
ASCVD - Atherosclerotic Cardiovascular Disease
1 trial -
MK-6194, Placebo for MK-6194
Merck Sharp and Dohme
Systemic Lupus Erythematosus
1 trial -
MT-7117 Formulation Code C, MT-7117 Placebo
Lacuna Pharma Pty Ltd
Erythropoietic Protoporphyria or X-Linked Protoporphyria
1 trial -
Matched placebo for product, Frexalimab
Sanofi-aventis Healthcare Pty Ltd
Multiple sclerosis
1 trial -
Matched placebo for test product, Duvakitug
Sanofi-aventis Healthcare Pty Ltd
Immune system disseases
1 trial -
Matched placebo for test product, Itepekimab
Sanofi-aventis Healthcare Pty Ltd
Chronic Obstructive Pulmonary Disease
1 trial -
Matched placebo for test product, Itepekimab
Sanofi-aventis Healthcare Pty Ltd
Chronic rhinosinusitis with nasal polyps
1 trial -
Matched placebo for test product, Itepekimab
Sanofi-aventis Healthcare Pty Ltd
Chronic rhinosinusitis with nasal polyps
1 trial -
Matching Placebo
IRONWOOD PHARMACEUTICALS INC
Chronic Constipation
1 trial -
Matching Placebo for Piclidenoson, Piclidenoson
Can-Fite BioPharma
Plaque psoriasis
1 trial -
Matching Placebo for TAK-279, ZASOCITINIB
Takeda
Plaque Psoriasis
1 trial -
Matching Placebo for Upadacitinib
AbbVie
Crohn's Disease
1 trial -
Matching placebo tablet, JNJ-67953964
Janssen-Cilag International N.V.
Major Depressive Disorder (MDD) with Moderate-to-severe Anhedonia
1 trial -
Matching placebo tablet, JNJ-67953964
Janssen-Cilag International N.V.
Major Depressive Disorder (MDD) with Moderate-to-severe Anhedonia
1 trial -
Mavorixafor, Mavorixafor Placebo Capsules
X4 Pharmaceuticals, Inc
Neutropenias
1 trial -
Mavorixafor, Placebo to Test IMP
X4 Pharmaceuticals, Inc
WHIM Syndrome
1 trial -
Mezagitamab, Placebo matching for Mezagitamab
Takeda
Chronic Primary Immune Thrombocytopenia
1 trial -
Mitapivat Matched Placebo
Agios Netherlands B.V.
Transfusion-dependent Alpha-Thalassemia
1 trial -
Modiodal 100 mg tabletten, PLACEBO
Disc Medicine
Inflammatory bowel disease, Fatigue
1 trial -
NIFEDIPINE, Placebo of Nifedipine
Pari Pharma GmbH
obstetric_pathological delivery
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.